Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy

被引:30
作者
Muratori, Paolo [1 ,2 ]
Lalanne, Claudine [1 ,2 ]
Barbato, Erica [1 ,2 ]
Fabbri, Angela [1 ,2 ]
Cassani, Fabio [1 ,3 ]
Lenzi, Marco [1 ,2 ]
Muratori, Luigi [1 ,2 ]
机构
[1] Policlin St Orsola, Ctr Studio & Cura Malattie Autoimmuni Fegato & Vi, I-40138 Bologna, Italy
[2] Univ Bologna, Dipartimento Sci Med & Chirurg, Alma Mater Studiorum, Bologna, Italy
[3] Univ Bologna, Policlin St Orsola, Azienda Osped, Bologna, Italy
关键词
Autoantibodies; Liver; Human; Female; Outcome; KIDNEY MICROSOME ANTIBODY; CLINICAL-FEATURES; LIVER-DISEASE; TYPE-1; CHILDREN; EXPERIENCE; MANAGEMENT; AUTOANTIBODIES; PHENOTYPE; DIAGNOSIS;
D O I
10.1016/j.cgh.2015.07.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Patients with autoimmune hepatitis (AIH) can present with symptoms ranging from those that are insidious and nonspecific to acute hepatitis with jaundice. However, some patients have no symptoms at diagnosis and are identified incidentally. We investigated disease progression and outcomes of these 2 groups of patients. METHODS: We performed a retrospective study to compare clinical, immunologic, and histologic features and outcomes of patients with asymptomatic vs symptomatic AIH. We analyzed data collected from 305 patients (90 asymptomatic and 215 with symptoms), diagnosed with AIH from 1994 and 2013, at the Center for the Study and Treatment of the Autoimmune Diseases of the Liver and Biliary System in Bologna, Italy. RESULTS: At diagnosis, patients with asymptomatic AIH had significantly lower mean levels of alanine aminotransferase (7.0 +/- 8.0-fold the upper limit of normal) than patients with symptomatic disease (23.0 +/- 18.0-fold the upper limit of normal; P < .001), and lower mean levels of bilirubin (1.4 +/- 1.4 mg/dL vs 8.6 +/- 10.4 mg/dL; P < .001). Asymptomatic patients also had significantly lower histologic grades (7.0 +/- 2.5) than symptomatic patients (9.0 +/- 2.9; P < .001). However, larger proportions of asymptomatic patients had anti-liver/kidney microsomal antibodies type 1 (26.8% vs 13.1%; P < .006), and associated autoimmune thyroid (26.7% vs 12.6%; P = .003) or skin (8.9% vs 2.3%; P = .010) disorders. Age at onset, sex, response to therapy, disease progression, genetic factors, and other autoantibody markers did not differ between patients with asymptomatic vs symptomatic disease. CONCLUSIONS: Patients with asymptomatic vs symptomatic AIH have similar courses of disease progression and responses to immunosuppressive agents, and therefore should receive the same treatment. Patients affected by thyroid or dermatologic autoimmune disorders are at increased risk of developing subclinical liver disease, and should be assessed routinely for AIH.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 38 条
[1]   Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis - An Italian experience [J].
Bianchi, FB ;
Cassani, F ;
Lenzi, M ;
Ballardini, G ;
Muratori, L ;
Giostra, F ;
Zauli, D .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (01) :166-171
[2]   Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly [J].
Czaja, AJ ;
Carpenter, HA .
HEPATOLOGY, 2006, 43 (03) :532-538
[3]   Behavior and significance of autoantibodies in type 1 autoimmune hepatitis [J].
Czaja, AJ .
JOURNAL OF HEPATOLOGY, 1999, 30 (03) :394-401
[4]   Acute and Acute Severe (Fulminant) Autoimmune Hepatitis [J].
Czaja, Albert J. .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (04) :897-914
[5]   Features and consequences of untreated type 1 autoimmune hepatitis [J].
Czaja, Albert J. .
LIVER INTERNATIONAL, 2009, 29 (06) :816-823
[6]   Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1 [J].
de Boer, Ynto S. ;
van Gerven, Nicole M. F. ;
Zwiers, Antonie ;
Verwer, Bart J. ;
van Hoek, Bart ;
van Erpecum, Karel J. ;
Beuers, Ulrich ;
van Buuren, Henk R. ;
Drenth, Joost P. H. ;
den Ouden, Jannie W. ;
Verdonk, Robert C. ;
Koek, Ger H. ;
Brouwer, Johannes T. ;
Guichelaar, Maureen M. J. ;
Vrolijk, Jan M. ;
Kraal, Georg ;
Mulder, Chris J. J. ;
van Nieuwkerk, Carin M. J. ;
Fischer, Janett ;
Berg, Thomas ;
Stickel, Felix ;
Sarrazin, Christoph ;
Schramm, Christoph ;
Lohse, Ansgar W. ;
Weiler-Normann, Christina ;
Lerch, Markus M. ;
Nauck, Matthias ;
Voelzke, Henry ;
Homuth, Georg ;
Bloemena, Elisabeth ;
Verspaget, Hein W. ;
Kumar, Vinod ;
Zhernakova, Alexandra ;
Wijmenga, Cisca ;
Franke, Lude ;
Bouma, Gerd .
GASTROENTEROLOGY, 2014, 147 (02) :443-+
[7]   Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome [J].
Feld, JJ ;
Dinh, H ;
Arenovich, T ;
Marcus, VA ;
Wanless, IR ;
Heathcote, EJ .
HEPATOLOGY, 2005, 42 (01) :53-62
[8]   Autoimmune hepatitis: Contrasts and comparisons in children and adults - A comprehensive review [J].
Floreani, Annarosa ;
Liberal, Rodrigo ;
Vergani, Diego ;
Mieli-Vergani, Giorgina .
JOURNAL OF AUTOIMMUNITY, 2013, 46 :7-16
[9]   British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis [J].
Gleeson, Dermot ;
Heneghan, Michael A. .
GUT, 2011, 60 (12) :1611-1629
[10]   Clinical features of type 1 autoimmune hepatitis in elderly Italian patients [J].
Granito, A ;
Muratori, L ;
Pappas, G ;
Muratori, P ;
Ferri, S ;
Cassani, F ;
Lenzi, M ;
Bianchi, FB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (10) :1273-1277